Nutra Pharma Corporation (OTCMKTS:NPHC) Stock Turns Volatile: What’s The Buzz?

August 1, 2021

Biotech company marketing Nyloxin, Pet Pain-Away, Equine Pain-Away as well as Luxury Feet, Nutra Pharma Corporation (OTCMKTS:NPHC) on July 26, 2021 announced filing a new provisional patent for protecting its IPR surrounding development of nerve agent counter measures. Rik J Deitsch, Chief Executive Officer of Nutra Pharma, said that the firm had announced project back in 2018. Deitsch added that the company findings demonstrate that the company’s products may protect…


Nutra Pharma Corporation (OTCMKTS: NPHC) Announces Availability of Nyloxin at Diverse Health Services

July 27, 2021

Nutra Pharma Corporation (OTCMKTS: NPHC) has announced the addition of the Nyloxin product line to Metro-Detroit’s Diverse Health Services’ offerings. Already Nyloxin is being offered in-house at the Diverse health Services’ facilities and will now be included on the online marketplace.  Nyloxin available at Diverse Health facilities  The marketing plan involves direct patient sales and other facilities, videos that will feature Dr. R.E Tent, and sales via social media and…


Nutra Pharma Corp. (OTCMKTS: NPHC) announces that Diverse Health Services has included Nyloxin in its produce submissions

July 24, 2021

Nutra Pharma Corp. (OTCMKTS: NPHC) announced that Diverse Health Services of Metro-Detroit had included the Nyloxin line of produces in their submissions. Diverse Health Services to the market line of products using different platforms Nyloxin is now being marketed in-house at their amenities and will be included presently in their online bazaar. Their promotion plan includes uninterrupted transactions to patients and other medical amenities, transactions through their websites and social…